NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 38 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | -100.0% | 316 | -99.1% | 0.00% | – |
| Q1 2021 | $80,000 | -10.1% | 36,000 | 0.0% | 0.00% | – |
| Q4 2020 | $89,000 | 0.0% | 36,000 | 0.0% | 0.00% | – |
| Q3 2020 | $89,000 | -30.5% | 36,000 | 0.0% | 0.00% | – |
| Q2 2020 | $128,000 | +312.9% | 36,000 | +126.4% | 0.00% | – |
| Q1 2019 | $31,000 | +47.6% | 15,900 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -46.2% | 15,900 | 0.0% | 0.00% | – |
| Q3 2018 | $39,000 | -26.4% | 15,900 | 0.0% | 0.00% | – |
| Q2 2018 | $53,000 | +60.6% | 15,900 | +101.3% | 0.00% | – |
| Q1 2018 | $33,000 | +26.9% | 7,900 | 0.0% | 0.00% | – |
| Q4 2017 | $26,000 | +36.8% | 7,900 | +54.9% | 0.00% | – |
| Q3 2017 | $19,000 | -13.6% | 5,100 | 0.0% | 0.00% | – |
| Q2 2017 | $22,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |